Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.285 GBX | -17.88% | +7.70% | -44.32% |
May. 20 | London gets boost thanks to rate cut hopes | AN |
May. 20 | ValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grant | AN |
Business Summary
Number of employees: 8
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Development
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Suzanne Dilly
CEO | Chief Executive Officer | 46 | - |
Gerald Desler
DFI | Director of Finance/CFO | 79 | 06-08-31 |
Chief Tech/Sci/R&D Officer | - | 22-09-07 | |
Kumar Nawani
COO | Chief Operating Officer | - | - |
Mark Treharne
PRN | Corporate Officer/Principal | - | 20-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Desler
DFI | Director of Finance/CFO | 79 | 06-08-31 |
Kevin Cox
CHM | Chairman | 65 | 20-06-25 |
Director/Board Member | 57 | Feb. 28 | |
Suzanne Dilly
CEO | Chief Executive Officer | 46 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 132,348,673 | 110,208,233 ( 83.27 %) | 0 | 83.27 % |
Company contact information
ValiRx Plc
Eliot Park Innovation Centre 4 Barling Way
CV10 7RH, Nuneaton
+44 24 7679 6496
http://www.valirx.comSector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.32% | 6.73M | |
+9.58% | 115B | |
+12.41% | 107B | |
-12.38% | 22.31B | |
-3.64% | 21.6B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B | |
-24.50% | 8.28B |
- Stock Market
- Equities
- VAL Stock
- Company ValiRx plc